A carregar...

Current treatment algorithm for the management of lower-risk MDS

Lower risk myelodysplastic syndromes (MDS), defined as MDS with a Revised International Prognostic Scoring System score ≤3.5 points, will remain a challenging entity in 2018. Supportive care continues to be the linchpin of treatment, although the options to reduce transfusion needs are broadening. T...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hematology Am Soc Hematol Educ Program
Autor principal: Giagounidis, Aristoteles
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6142548/
https://ncbi.nlm.nih.gov/pubmed/29222293
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!